Expanded Access Protocol of BHV-0223 for Patients With Amyotrophic Lateral Sclerosis (ALS)
Conditions: Amyotrophic Lateral Sclerosis; ALS; Lou Gehrig Disease; Lou Gehrig's Disease; Lou-Gehrigs Disease; Motor Neuron Disease, Amyotrophic Lateral Sclerosis Intervention: Drug: Riluzole Sponsor: Biohaven Pharmaceutical Holding Company Ltd. Available
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials